Additionally, Luteolin was found to decrease the purine-rich element binding protein B (PURB), targeted by miR-133a-3p levels in vascular endothelial cells of NSCLC, and when PURB was silenced, the miR-133a-3p levels increased. The gene discussed is PURB; the disease is non-small cell lung carcinoma.